Home › Funds › MONIMUS CAPITAL MANAGEMENT, LP › ASMB

MONIMUS CAPITAL MANAGEMENT, LP position in ASMB

ASSEMBLY BIOSCIENCES INC · Health Care

MONIMUS CAPITAL MANAGEMENT, LP reported holding 47,580 shares of ASMB (ASSEMBLY BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$1.1M, representing 0.27% of its reported portfolio and ranking #50 among its reported holdings. MONIMUS CAPITAL MANAGEMENT, LP has disclosed ASMB holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)47.58K sh
Reported value held$1.12M
Portfolio Weight0.27%
First reportedQ4 2024
Last changeHold
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How MONIMUS CAPITAL MANAGEMENT, LP's ASMB position evolved

MONIMUS CAPITAL MANAGEMENT, LP first disclosed a stake in ASMB in Q4 2024 at 42,067 shares (US$664K). The position peaked in Q1 2026 at 48,390 shares, worth US$1.3M. Across 8 filings, MONIMUS CAPITAL MANAGEMENT, LP increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 47,580 shares valued at US$1.1M. Notable position changes include a 26% increase in Q1 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 42.07K $663.82K New
Q1 2025 42.07K $402.16K Hold
Q2 2025 42.07K $762.25K Hold
Q3 2025 42.07K $1.08M Hold
Q4 2025 38.30K $1.30M Reduce
Q1 2026 48.39K $1.34M Add
Q2 2026 47.58K $1.31M Reduce
Q3 2026 47.58K $1.12M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ASMB and 13F data

ASMB (ASSEMBLY BIOSCIENCES INC) is a Health Care company. 54 other funds we track also report a position in ASMB — the largest reported positions include GILEAD SCIENCES, INC. (US$116.9M), Farallon Capital Management (US$44.1M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$37.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ASMB

All ASMB fund holders →

FAQ

How long has MONIMUS CAPITAL MANAGEMENT, LP held ASMB?

MONIMUS CAPITAL MANAGEMENT, LP has disclosed ASMB holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is MONIMUS CAPITAL MANAGEMENT, LP's current position in ASMB?

As of Q3 2026, MONIMUS CAPITAL MANAGEMENT, LP holds 47.58K shares of ASMB (ASSEMBLY BIOSCIENCES INC), valued at $1.12M, representing 0.27% of its reported portfolio and ranking #50.

Has MONIMUS CAPITAL MANAGEMENT, LP been buying or selling ASMB?

In the latest 13F filing (Q3 2026), MONIMUS CAPITAL MANAGEMENT, LP held unchanged its position in ASMB. The position peaked in Q1 2026 at 48.39K shares.

Which other funds hold ASMB?

Other major institutional holders of ASMB include GILEAD SCIENCES, INC., Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 54 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.